Parade on MSN

How Cycle Syncing for 2 Months Improved My Workouts and Nutrition

There's power in working with your body instead of against it.

Hailey Bieber Loves Cold Plunges—But Should Women Be Doing Them?

The question is more complicated than you might think.
Tyla

Valentine’s Day warning issued for anyone who was on their period last week

Women have flocked to social media to share a Valentine's Day warning for anyone who was on their period last week as it ...

Lyell doses first patient in Phase III trial for LBCL

Lyell Immunopharma has dosed the first patient in its PiNACLE – H2H Phase III chimeric antigen receptor (CAR)-cell trial for ...

“It’s like a personal sleep coach on your finger”: Oura Ring 4 vs Gen 3, tested for 6 months

Me 🤝 wearing my ring 24/7 ...
The Manila Times

Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma

PiNACLE - H2H will evaluate the efficacy and safety of rondecabtagene autoleucel (ronde-cel) versus Investigator’s choice of ...
Medindia

Ancient Chinese Herb Triggers Hair Regrowth Pathway

Study shows a traditional Chinese root extract activates Wnt beta catenin signalling and boosts hair follicle growth in lab models for hair loss therapy.
HDsports

Carbo-Loading Before the Marathon: The 7 Most Important Tips & Example Schedule

A marathon is not only a physical test but also a matter of proper energy supply. To successfully cover the distance of ...

Incyte Corporation (NASDAQ: INCY) Q4 2025 earnings call transcript

Incyte Corporation (NASDAQ:INCY) Q4 2025 Earnings Call Transcript February 10, 2026 Incyte Corporation misses on earnings expectations. Reported EPS is $1.46 EPS, expectations were $1.94. Operator: ...
Le Lézard

AutoIVF Publishes Peer-Reviewed Nature Medicine Study Evaluating Oocyte Recovery Variability in IVF Using an Automated Microfluidic System

AutoIVF, a fertility technology company developing automated solutions for reproductive medicine, today announced the publication of a peer-reviewed clinical study in Nature Medicine describing the ...

Lyell Immunopharma, Inc: Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B ...

PiNACLE - H2H will evaluate the efficacy and safety of rondecabtagene autoleucel (ronde-cel) versus Investigator's choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell ...